ArticleBulletin of the World Health Organization2014
Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study.
Article in Bulletin of the World Health Organization, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
111 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- A Systematic Literature Review and Network Meta-analysis of Azilsartan Medoxomil Compared to Other Anti-hypertensives Efficacy in Lowering Blood Pressure Amongst Mild to Moderate Hypertensive Patients.Advances in therapy · 2024Pooled it
- Systematic literature review and meta-analysis of cardiovascular risk factor management in selected Asian countries.Journal of comparative effectiveness research · 2023Pooled it
- Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control.Current hypertension reports · 2019Pooled it
- Prevalence of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.Medicine · 2015Pooled it
- Trial
- Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial.BMJ evidence-based medicine · 2020Trial
- Effects of integrated chronic care models on hypertension outcomes and spending: a multi-town clustered randomized trial in China.BMC public health · 2017Trial
- Trial
- Family member-based supervision of patients with hypertension: a cluster randomized trial in rural China.Journal of human hypertension · 2017Trial
- A comparison of the quality of hypertension management in primary care between Shanghai and Shenzhen: a cohort study of 3196 patients.Medicine · 2015Trial
- One-year routine opportunistic screening for hypertension in formal medical settings and potential improvements in hypertension awareness among older persons in developing countries: evidence from the Study on Global Ageing and Adult Health (SAGE).American journal of epidemiology · 2015Trial
- Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort.BMJ open · 2014Trial
- Effects of spironolactone on dialysis patients with refractory hypertension: a randomized controlled study.Journal of clinical hypertension (Greenwich, Conn.) · 2014Trial
- County health rankings, provider shortages, and the health of incarcerated women with opioid use disorder.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026Article
- Associations Between Hearing Loss and Depressive Symptom Trajectories in Middle-Aged and Older People in China: Retrospective Analysis.JMIR aging · 2025Article
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study.Scientific reports · 2025Article
- Optimizing hypertension management in China: care cascade insights and individual determinants from a national survey.Current medical research and opinion · 2025Article
- Health Equity of Hypertension Management Between Local Residents and Internal Migrants in Shenzhen, China: Cross-Sectional Study.JMIR public health and surveillance · 2025Article
- Impact of the National Essential Public Health Service Package on Blood Pressure Control in Chinese People With Hypertension: Retrospective Population-Based Longitudinal Study.JMIR public health and surveillance · 2025Article
- Ranges, temporal trend, and determinants of novel obesity indices in middle-aged and older Chinese population: insights from a nationally representative and longitudinal study.Frontiers in public health · 2025Article
51 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo monitor hypertension prevalence, awareness, treatment and control in China two to three years after major reform of the health system.
methodsData from a national survey conducted in 2011-2012 among Chinese people aged 45 years or older - which included detailed anthropometric measurements - were used to estimate the prevalence of hypertension and the percentages of hypertensive individuals who were unaware of, receiving no treatment for, and/or not controlling their hypertension well. Modified Poisson regressions were used to estimate relative risks (RRs).
findingsAt the time of the survey, nearly 40% of Chinese people aged 45 years or older had a hypertensive disorder. Of the individuals with hypertension, more than 40% were unaware of their condition, about 50% were receiving no medication for it and about 80% were not controlling it well. Compared with the other hypertensive individuals, those who were members of insurance schemes that covered the costs of outpatient care were more likely to be aware of their hypertension (adjusted RR, aRR: 0.737; 95% confidence interval, CI: 0.619-0.878) to be receiving treatment for it (aRR: 0.795; 95% CI: 0.680-0.929) and to be controlling it effectively (aRR: 0.903; 95% CI: 0.817-0.996).
conclusionIn China many cases of hypertension are going undetected and untreated, even though the health system appears to deliver effective care to individuals who are aware of their hypertension. A reduction in the costs of outpatient care to patients would probably improve the management of hypertension in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.